The city of Lancaster, Pennsylvania, currently has 1 active clinical trials seeking participants for Lymphoma research studies.
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
Recruiting
This study will evaluate the efficacy, safety, and pharmacokinetics of mosunetuzumab subcutaneous (SC) formulation in participants with selected B-cell malignancies (types of non-Hodgkin's lymphoma [NHL]).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/23/2024
Locations: Lancaster General Hospital, Lancaster, Pennsylvania
Conditions: Non-Hodgkin Lymphoma